Edoxaban
| CAS No. | 480449-70-5 | Cat. No. | BCP04267 |
| Name | Edoxaban | ||
| Synonyms | DU-176; DU 176; DU176; | ||
| Formula | C24H30ClN7O4S | M. Wt | 548.06 |
| Description | Edoxaban is a potent, selective factor Xa inhibitor, which has good oral bioavailability. Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is being developed by Daiichi Sankyo. It was approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery. It was also approved by the FDA in January 2015 for the prevention of stroke and non–central-nervous-system systemic embolism. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Factor Xa | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.